文章预览
On September 8, 2024, the Ministry of Commerce, the National Health Commission and the National Medical Products Administration jointly issued the Notice on Expanding the Pilot Program for Opening Up in the Medical Field , announcing that, effective immediately, foreign-invested enterprises may engage in the development and application of human stem cell, gene diagnosis and therapy technologies (the “ Stem Cell and Gene Area ”) in the Beijing Pilot Free Trade Zone, the Shanghai Pilot Free Trade Zone, the Guangdong Pilot Free Trade Zone, and the Hainan Free Trade Port. From 2007, the Stem Cell and Gene Area has always been listed as one of the areas that foreign investment is prohibited. However, from 2019, the PRC government and the local governments of Shanghai, Beijing and Shenzhen began to promulgate different measures to gradually open up foreign investment in the Stem Cell and Gene Area. For example, on July 11, 2024, the Shanghai Commerce Commission and a few other Shang
………………………………
